Optimi Health Corp. (CSE:OPTI)

Market Cap	20.73M
Revenue (ttm)	517.48K
Net Income (ttm)	-6.05M
Shares Out	96.44M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,675
Average Volume	31,415
Open	0.2200
Previous Close	0.2150
Day's Range	0.2150 - 0.2200
52-Week Range	0.1450 - 0.5400
Beta	1.15
RSI	55.94
Earnings Date	Jun 2, 2025

About Optimi Health

Optimi Health Corp. produces and supplies psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. The company was incorporated in 2020 and is ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OPTI

Financial Performance

In 2024, Optimi Health's revenue was 389,850, an increase of 115.28% compared to the previous year's 181,087. Losses were -6.04 million, 16.2% more than in 2023.